Accelerating 3D Microtissue Production: Fast and efficient 3D microtissue production with the Viaflo 96 channel hand-held electronic pipette

Preclinical drug development relies on advanced in vitro models with a high degree of standardization to achieve maximal predictivity for an efficient compound de-risking strategy. This application note describes the successful production of 3D microtissues using the InSphero's GravityPLUS™ and GravityTRAP™ platforms in combination with the Integra Viaflo 96 Channel Electronic Hand-Held Pipette.